Found 364 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer N/A This is a feasibility study evaluating the use of a mathematical model to p...
Show More Location
University of New Mexico Comprehensive Cancer Center
Learn More & Join Trial
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma PHASE2 This study is being done to find out how effective a new treatment strategy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
PET in Breast Cancer Receiving Neoadjuvant Chemotherapy PHASE2 Prognostic factors in locally advanced breast cancer treated with neoadjuva...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer PHASE2 This multi-center, open-label, phase II randomized controlled trial is to e...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer PHASE2 Phase II trial to study the effectiveness of combination chemotherapy with ...
Show More Location
Eastern Cooperative Oncology Group
Learn More & Join Trial
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach PHASE2 RATIONALE: Drugs used in chemotherapy, such as docetaxel and epirubicin, wo...
Show More Location
Centre Paul Papin
Learn More & Join Trial
DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer PHASE2 Our study is a prospective, non-inferior, randomized phase II clinical tria...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer PHASE2 This is an open, multicenter, randomized controlled clinical study aimed to...
Show More Location
Multiple Locations
Learn More & Join Trial